IDEXX Laboratories Operating Margin 2010-2024 | IDXX
Current and historical operating margin for IDEXX Laboratories (IDXX) over the last 10 years. The current operating profit margin for IDEXX Laboratories as of March 31, 2024 is 23.26%.
| IDEXX Laboratories Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-03-31 | $3.73B | $1.12B | 29.92% |
| 2023-12-31 | $3.66B | $1.10B | 29.93% |
| 2023-09-30 | $3.59B | $1.08B | 30.04% |
| 2023-06-30 | $3.52B | $1.05B | 29.82% |
| 2023-03-31 | $3.43B | $0.93B | 27.13% |
| 2022-12-31 | $3.37B | $0.90B | 26.68% |
| 2022-09-30 | $3.34B | $0.87B | 26.07% |
| 2022-06-30 | $3.31B | $0.85B | 25.75% |
| 2022-03-31 | $3.27B | $0.93B | 28.47% |
| 2021-12-31 | $3.22B | $0.93B | 28.99% |
| 2021-09-30 | $3.14B | $0.92B | 29.28% |
| 2021-06-30 | $3.05B | $0.86B | 28.36% |
| 2021-03-31 | $2.86B | $0.80B | 27.91% |
| 2020-12-31 | $2.71B | $0.69B | 25.64% |
| 2020-09-30 | $2.59B | $0.63B | 24.12% |
| 2020-06-30 | $2.47B | $0.59B | 23.97% |
| 2020-03-31 | $2.46B | $0.56B | 22.96% |
| 2019-12-31 | $2.41B | $0.55B | 22.98% |
| 2019-09-30 | $2.35B | $0.55B | 23.49% |
| 2019-06-30 | $2.29B | $0.53B | 23.10% |
| 2019-03-31 | $2.25B | $0.51B | 22.70% |
| 2018-12-31 | $2.21B | $0.49B | 22.19% |
| 2018-09-30 | $2.17B | $0.47B | 21.84% |
| 2018-06-30 | $2.12B | $0.46B | 21.59% |
| 2018-03-31 | $2.05B | $0.43B | 21.22% |
| 2017-12-31 | $1.97B | $0.41B | 20.98% |
| 2017-09-30 | $1.91B | $0.40B | 20.93% |
| 2017-06-30 | $1.86B | $0.39B | 20.78% |
| 2017-03-31 | $1.82B | $0.37B | 20.22% |
| 2016-12-31 | $1.78B | $0.35B | 19.71% |
| 2016-09-30 | $1.73B | $0.33B | 19.22% |
| 2016-06-30 | $1.69B | $0.32B | 18.75% |
| 2016-03-31 | $1.64B | $0.30B | 18.39% |
| 2015-12-31 | $1.60B | $0.30B | 18.74% |
| 2015-09-30 | $1.55B | $0.27B | 17.26% |
| 2015-06-30 | $1.53B | $0.27B | 17.50% |
| 2015-03-31 | $1.51B | $0.26B | 17.44% |
| 2014-12-31 | $1.49B | $0.26B | 17.50% |
| 2014-09-30 | $1.49B | $0.29B | 19.22% |
| 2014-06-30 | $1.44B | $0.28B | 19.35% |
| 2014-03-31 | $1.41B | $0.28B | 19.57% |
| 2013-12-31 | $1.38B | $0.27B | 19.32% |
| 2013-09-30 | $1.34B | $0.27B | 19.96% |
| 2013-06-30 | $1.32B | $0.27B | 20.15% |
| 2013-03-31 | $1.30B | $0.26B | 20.18% |
| 2012-12-31 | $1.29B | $0.26B | 20.25% |
| 2012-09-30 | $1.28B | $0.25B | 19.83% |
| 2012-06-30 | $1.27B | $0.25B | 19.49% |
| 2012-03-31 | $1.25B | $0.24B | 19.38% |
| 2011-12-31 | $1.22B | $0.24B | 19.36% |
| 2011-09-30 | $1.20B | $0.23B | 19.40% |
| 2011-06-30 | $1.17B | $0.23B | 19.40% |
| 2011-03-31 | $1.13B | $0.21B | 18.62% |
| 2010-12-31 | $1.10B | $0.20B | 18.48% |
| 2010-09-30 | $1.09B | $0.20B | 18.07% |
| 2010-06-30 | $1.08B | $0.19B | 17.70% |
| 2010-03-31 | $1.06B | $0.19B | 17.39% |
| 2009-12-31 | $1.03B | $0.18B | 16.97% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $39.691B | $3.661B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributer of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.485B | 26.48 |
| Intuitive Surgical (ISRG) | United States | $135.271B | 81.49 |
| Edwards Lifesciences (EW) | United States | $51.372B | 33.43 |
| DexCom (DXCM) | United States | $51.051B | 77.33 |
| IQVIA Holdings (IQV) | United States | $40.698B | 23.61 |
| Alcon (ALC) | Switzerland | $39.236B | 28.93 |
| STERIS (STE) | Ireland | $20.536B | 24.31 |
| Waters (WAT) | United States | $19.053B | 27.34 |
| Hologic (HOLX) | United States | $17.966B | 19.98 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.387B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.392B | 85.37 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.306B | 15.20 |
| Sysmex ADR (SSMXY) | Japan | $10.920B | 34.24 |
| Teleflex (TFX) | United States | $9.562B | 14.88 |
| Penumbra (PEN) | United States | $8.083B | 99.79 |
| Masimo (MASI) | United States | $7.249B | 40.65 |
| Globus Medical (GMED) | United States | $7.033B | 22.30 |
| Glaukos (GKOS) | United States | $5.346B | 0.00 |
| TransMedics (TMDX) | United States | $4.216B | 399.97 |
| Integer Holdings (ITGR) | United States | $3.728B | 22.52 |
| LivaNova (LIVN) | United Kingdom | $3.474B | 20.63 |
| PROCEPT BioRobotics (PRCT) | United States | $3.307B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.888B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.712B | 18.60 |
| Nihon Kohden (NHNKY) | Japan | $2.490B | 21.06 |
| Inari Medical (NARI) | United States | $2.444B | 0.00 |
| RxSight (RXST) | United States | $2.281B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.271B | 9.32 |
| Alphatec Holdings (ATEC) | United States | $1.908B | 0.00 |
| Veracyte (VCYT) | United States | $1.556B | 0.00 |
| OPKO Health (OPK) | United States | $0.906B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.903B | 17.57 |
| Paragon 28 (FNA) | United States | $0.873B | 0.00 |
| Artivion (AORT) | United States | $0.862B | 99.67 |
| Silk Road Medical (SILK) | United States | $0.800B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.781B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.679B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.623B | 21.15 |
| SiBone (SIBN) | United States | $0.585B | 0.00 |
| IRadimed (IRMD) | United States | $0.566B | 31.70 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.509B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.498B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.432B | 0.00 |
| Nevro (NVRO) | United States | $0.414B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.339B | 11.42 |
| Sight Sciences (SGHT) | United States | $0.295B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.265B | 0.00 |
| AxoGen (AXGN) | United States | $0.253B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.251B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.199B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.190B | 10.23 |
| 908 Devices (MASS) | United States | $0.186B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| Accuray (ARAY) | United States | $0.161B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.159B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.154B | 0.00 |
| Neuronetics (STIM) | United States | $0.114B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.106B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Envoy Medical (COCH) | United States | $0.085B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.061B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.060B | 121.67 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| InspireMD (NSPR) | Israel | $0.047B | 0.00 |
| DarioHealth (DRIO) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.038B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| PAVmed (PAVM) | United States | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |